Gabriel Valentín-Guillama retweeted
Congrats to Akash Shah, MD on successfully defending his thesis! 🎉
As a gynecologic oncology fellow, Akash spent a year conducting translational research with @TheHedrickLab.
"Dr. Hedrick was an amazing mentor and turned a clinician into an immunologist."
#IMMCG #Research
Gabriel Valentín-Guillama retweeted
Congratulations to @adil__rasheed for earning the "Biomedicines" Young Investigator Award. Dr. Rasheed's research is focused on the intersection of lipid metabolism with immune cell fate and function in atherosclerotic cardiovascular disease.
📰 - bit.ly/4tttV5h
Gabriel Valentín-Guillama retweeted
BALDWIN: Do you think NIH should fund less cancer research?
RFK Jr: No, they should fund more, and one of the few agencies that got a raise in the budget proposal was NCI
BALDWIN: And that increase is less than $1 million for an institute with a $7 billion budget. That's a .01% increase. It wouldn't even cover the cost of one additional grant.
Gabriel Valentín-Guillama retweeted
We are excited to have such a strong representation at Immunology 2026 hosted by the American Association of Immunologists in Boston this week. Here is a quick snapshot of where IMMCG researchers and trainees will be throughout the week.
Gabriel Valentín-Guillama retweeted
March is Women’s History Month and yesterday we celebrated International Women’s Day. As we take this time to celebrate the contributions of women to science, several of our researchers and trainees took some time to reflect on the women who inspired them to study the sciences.
Gabriel Valentín-Guillama retweeted
Devadatta Gosavi recently presented his work using TIRF microscopy & sensitized FRET to investigate the spatiotemporal coordination between talin-1 & kindlin-3 to elucidate the molecular mechanisms governing β₂-integrin activation & advance understanding of immune regulation.
Back in 2022, joining IMMCG as a new postdoc in a brand-new center felt like a leap of faith. Three years later, I’ve found not just great science, but also the joy of helping build a thriving community, and having so much fun along the way. To many more years! 🎉
From fewer than 20 at our first potluck to 90+ at this year’s anniversary ice cream social 🎉 IMMCG has grown so much in 3 years — in people, programs, and community.
We’re proud of what we’ve built together & excited for what’s ahead! #ImmunityStrong #Anniversary
Gabriel Valentín-Guillama retweeted
Our team had a fantastic time at #AAI2025! These meetings remind us how collaboration drives discovery and inspires innovation. We're grateful to be part of this global community! 🌍🔬
#IMMUNOLOGY2025 @ImmunologyAAI
Time to say goodbye to Honolulu after an awesome conference—great science, even better people, and a whole lot of hope for what’s ahead. #Immunology2025
Gabriel Valentín-Guillama retweeted
Very happy our new review in the role of foamy macrophages in atherosclerosis is published. Check it out! @ImmunologyAU #OrecchioniLab
frontiersin.org/journals/car…
Why is the NIH investing $$ to study "transgender" mice🐭? 🤔 Let me explain 👇 🧵
TL;DR This has everything to do with your health and nothing to do with making people #transgender. #ScienceSavesLives
Gabriel Valentín-Guillama retweeted
Are you interested in human brain immunology and cancer?
We have an open PhD position come and join us! kidoktorand.varbi.com/en/wha… @slinnarsson @karolinskainst – at Stockholm, Sweden
Gabriel Valentín-Guillama retweeted
Let’s talk numbers. Puerto Rico is the #1 bioscience manufacturing hub in the United States. We keep hearts beating, insulin circulating and eyes focusing nationwide and around the world. We are a powerhouse of science and engineering, beyond beautiful beaches. #WorldClassExperts
Gabriel Valentín-Guillama retweeted
Join us as we learn more about #HPV on the latest episode of A Cancer Conversation.
Youtube: youtube.com/watch?v=8PXlVowE…
Spotify: spotifyanchor-web.app.link/e…
The sniffing 👃 Macrophages are at it again! ⬇️
I’m excited to share that our latest work delving into the biology and function of Olfr2-expressing macrophages in atherosclerosis is finally out on Cardiovascular Research! A big thank you to all our collaborators. #OrecchioniLab,
@ImmunologyAU
academic.oup.com/cardiovascr…
Ending Day 1 of #SIS2024 with a visit to the Birmingham Civil Rights Institute - an inspiring reminder of of the power of resilience and the importance of Justice. @ImmunologyAU
Gabriel Valentín-Guillama retweeted
Colonna and colleagues provide a resource of ILC1 heterogeneity in human tissues. Read it here: rdcu.be/dM64F
nature.com/articles/s41590-0…
Gabriel Valentín-Guillama retweeted
Looking for a postdoc position and interested in the intersection of immunometabolism in cardiovascular disease? Come join our team!! 👇
careers.hprod.onehcm.usg.edu…



































